Blueprint Medicines Reports First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Buildings collapse as quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Blueprint Medicines (BPMC) Tops Q1 EPS by 13c
May 10, 2016 8:45 AM EDTBlueprint Medicines (NASDAQ: BPMC) reported Q1 EPS of ($0.57), $0.13 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $6.86 million versus the consensus estimate of $3.24 million.
Blueprint Medicines expects that its cash, cash equivalents and investments balance will be at least $120 million at... More
